Maximal actomyosin ATPase activity and in vitro myosin motility are unaltered in human mitral regurgitation heart failure

Circulation Research

Volumn 79, Issue 2, 1996, Pages 222-226

  Nguyen, The Tin T ^a   Hayes, Eric ^b   Mulieri, Louis A ^b   Leavitt, Bruce J ^b   Ter Keurs, Henk E D J ^a   Alpert, Norman R ^b   Warshaw, David M ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

actin filament; biopsy; cardiac muscle; cardiomyopathy; crossbridge

Indexed keywords

ACTIN; MYOSIN; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN HEAVY CHAIN; TROPOMYOSIN;

ACTIN MYOSIN INTERACTION; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVATION; HEART DILATATION; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030056230     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.2.222     Document Type: Article

References (31)

1. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56-64.
2. Eckberg DL, Gault JH, Bouchard RL, Karliner JS, Ross J Jr. Mechanics of left ventricular contraction in chronic severe mitral regurgitation. Circulation. 1973;47:1252-1259.
3. Hasenfuss G, Mulieri LA, Blanchard EM, Holubarsch C, Leavitt BJ, Ittleman F, Alpert NR. Energetics of isometric force development in control and volume-overload human myocardium: comparison with animal species. Circ Res. 1991;68:836-846.
4. Mulieri LA, Leavitt BJ, Martin BJ, Haeberle JR, Alpert NR. Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation. 1993;88:2700-2704.
5. Peters TJ, Wells G, Oakley CM, Brooksby IA, Jenkins BS, Webb-Peploe MM, Coltart DJ. Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. Br Heart J. 1977;39:1333-1339.
6. Pagani ED, Alousi AA, Grant AM, Older TM, Dziuban SW Jr, Allen PD. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res. 1988;63:380-385.
7. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle JR, Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res. 1992;70:1225-1232.
8. Rupp H, Jacob R. Structural and functional diversity of human ventricular myosin. Basic Res Cardiol. 1992;87(suppl 1):95-106.
9. Morano I. Effects of different expression and post-translational modifications of myosin light chains on contractility of skinned human cardiac fibers. Basic Res Cardiol. 1992;87(suppl 1):129-142.
10. Sutsch G, Brunner UT, Schulthess CV, Hirzel HO, Hess OM, Turina M, Krayenbuehl HP, Schaub MC. Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Basic Res Cardiol. 1992;87(suppl 1):285-290.
11. Hirzel HO, Tuchschmid CR, Schneider J, Krayenbuehl HP, Schaub MC. Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy. Circ Res. 1985;57:729-740.
12. Anderson PA, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in the normal and failing human left ventricle: a correlation with myofibrillar ATPase activity. Basic Res Cardiol. 1992;87(suppl 1):117-127.
13. Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in humans: a comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res. 1991;69:1226-1233.
14. Alpert NR, Gordon MS. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol. 1962;205:940-946.
15. Price KM, Littler WA, Cummins P. Myosin adenosinetriphosphatase activity and light chain subunit composition of human right and left ventricle. Cardiovasc Res. 1980;14:555-560.
16. Alousi AA, Grant AM, Etzler JR, Cofer BR, Van der Bel-Kahn J, Melvin D. Reduced cardiac myofibrillar Mg-ATPase activity without changes in myosin isozymes in patients with end-stage heart failure. Mol Cell Biochem. 1990;96:79-88.
17. Solaro RJ, Powers FM, Gao L, Gwathmey JK. Control of myofilament activation in heart failure. Circulation. 1993;87(suppl VII): VII-38-VII-43.
18. Mulieri LA, Leavitt BJ, Hasenfuss G, Allen PD, Alpert NR. Contraction frequency dependence of twitch and diastolic tension in human dilated cardiomyopathy (tension-frequency relation in cardiomyopathy). Basic Res Cardiol. 1992;87(suppl 1):199-212.
19. Mulieri LA, Hasenfuss G, Ittleman F, Blanchard EM, Alpert NR. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res. 1989;65:1441-1449.
20. Warshaw DM, Desrosiers JM, Work SS, Trybus KM. Smooth muscle myosin cross-bridge interactions modulate actin filament sliding velocity in vitro. J Cell Biol. 1990;111:453-463.
21. Lanzetta PA, Alvarez LJ, Reinach PS, Candia OA. An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem. 1979;100:95-97.
22. Work SS, Warshaw DM. Computer-assisted tracking of actin filament motility. Anal Biochem. 1992;202:275-285.
23. Mercadier JJ, Bouveret P, Gorza L, Schiaffino S, Clark WA, Zak R, Swynghedauw B, Schwartz K. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ Res. 1983;53:52-62.
24. Schier JJ, Adelstein RS. Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults, and patients with hypertrophic cardiomyopathy. J Clin Invest. 1982;69:816-825.
25. Lauer B, Van Thiem N, Swynghedauw B. ATPase activity of the cross-linked complex between cardiac myosin subfragment 1 and actin in several models of chronic overloading: a new approach to the biochemistry of contractility. Circ Res. 1989;64:1106-1115.
26. Siegman MJ, Mooers SU, Warren TB, Warshaw DM, Ikebe M, Butler TM. Comparison of the effects of 2,3-butanedione monoxime on force production, myosin light chain phosphorylation and chemical energy usage in intact and permeabilized smooth and skeletal muscles. J Muscle Res Cell Motil. 1994;15:457-472.
27. Hajjar RJ, Gwathmey JK. Cross-bridge dynamics in human ventricular myocardium: regulation of contractility in the failing heart [published erratum appears in Circulation 1994;89:509]. Circulation. 1992;86:1819-1826.
28. de Tombe PP, ter Keurs HEDJ. An internal viscous element limits unloaded velocity of sarcomere shortening in rat myocardium. J Physiol (Land). 1992;454:619-642.
29. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Holubarsch C, Just H, Alpert NR. Contractile protein function in failing and nonfailing human myocardium. Basic Res Cardiol. 1992;87(suppl 1):107-116.
30. Alpert NR, Hasenfuss G, Mulieri LA, Blanchard EM, Leavitt BJ, Ittleman F. The reorganization of the human and rabbit heart in response to haemodynamic overload. Eur Heart J. 1992;13(suppl D):9-16.
31. Finer JT, Simmons RM, Spudich JA. Single myosin molecule mechanics: piconewton forces and nanometre steps. Nature. 1994;368:113-119.